rs1557229683
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PM2PM5PP3_StrongPP5
The NM_001360016.2(G6PD):c.1187C>T(p.Pro396Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/19 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P396A) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001360016.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
G6PD | NM_001360016.2 | c.1187C>T | p.Pro396Leu | missense_variant | 10/13 | ENST00000393562.10 | |
G6PD | NM_000402.4 | c.1277C>T | p.Pro426Leu | missense_variant | 10/13 | ||
G6PD | NM_001042351.3 | c.1187C>T | p.Pro396Leu | missense_variant | 10/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
G6PD | ENST00000393562.10 | c.1187C>T | p.Pro396Leu | missense_variant | 10/13 | 1 | NM_001360016.2 | P4 |
Frequencies
GnomAD3 genomes ? Cov.: 24
GnomAD4 exome Cov.: 33
GnomAD4 genome ? Cov.: 24
ClinVar
Submissions by phenotype
Anemia, nonspherocytic hemolytic, due to G6PD deficiency Pathogenic:1Uncertain:1
Pathogenic, criteria provided, single submitter | curation | Dunham Lab, University of Washington | Aug 12, 2022 | Variant found in hemizygote with deficiency and CNSHA (PP4). Decreased activity in red blood cells (1%) (PS3). Predicted to be damaging or deleterious by multiple computational algorithms (PP3). Within dimer interface (PM1). Not found in gnomAD (PM2). Post_P 0.994 (odds of pathogenicity 1517, Prior_P 0.1). - |
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Dec 13, 2016 | This sequence change replaces proline with leucine at codon 396 of the G6PD protein (p.Pro396Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine. This variant is not present in population databases (ExAC no frequency). This variant has been reported in 2 individuals affected with chronic hemolytic anemia with evidence of segregation in one of the families (PMID: 7959695, Invitae). In addition, a different missense substitution at this codon has been reported de novo in an individual affected with G6PD-deficiency (PMID:26275698). One experimental study has shown that heterozygous females had lower levels of mutant mRNA with this variant as compared to the wild-type mRNA in blood cells, which might indicate a preferential survival of cells where the X inactivation is acting on the mutated chromosome (PMID: 8808605). In summary, this variant is a rare missense change that has been reported in affected individuals and suggested to affect blood cell survival. Additional genetic and functional data are needed to further substantiate the pathogenicity this variant. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at